FCC ID PH29433

PH2-9433, PH2 9433, PH29433

Dexcom, Inc. Glucose Monitor

An FCC ID is the product ID assigned by the FCC to identify wireless products in the market. The FCC chooses 3 or 5 character "Grantee" codes to identify the business that created the product. For example, the grantee code for FCC ID: PH29433 is . The remaining characters of the FCC ID, 9433, are often associated with the product model, but they can be random. These letters are chosen by the applicant. In addition to the application, the FCC also publishes internal images, external images, user manuals, and test results for wireless devices. They can be under the "exhibits" tab below.

Dexcom, Inc.

Full Company Details: Dexcom, Inc. - PH2
Company Code: PH2
Address:
   Dexcom, Inc.
   6340 Sequence Drive
   San Diego, CA 92121
   United States
App # Purpose Date Unique ID
1 Original Equipment 2010-11-09 qzL7DDdcLkCRsRCVFi4M1w==

Approved Operating Frequencies

Line EntryFrequency RangeRule Parts
12425.00000000-2477.0000000015C

Exhibits

All Available Documents

Document Type Submitted / Available
Schematics 1Schematics / Adobe Acrobat PDF (24 kB) 2010-11-08 /
Confidentiality LetterCover Letter(s) / Adobe Acrobat PDF (76 kB) 2010-11-08 / 2010-11-09
Internal PhotosInternal Photos / Adobe Acrobat PDF (473 kB) 2010-11-08 / 2010-11-09
Users ManualUsers Manual / Adobe Acrobat PDF (1640 kB) 2010-11-08 / 2010-11-09
Schematics 2Schematics / Adobe Acrobat PDF (24 kB) 2010-11-08 /
DescriptionOperational Description / Adobe Acrobat PDF (20 kB) 2010-11-08 /
Label and LocationID Label/Location Info / Adobe Acrobat PDF (313 kB) 2010-11-08 / 2010-11-09
Authorization LetterCover Letter(s) / Adobe Acrobat PDF (168 kB) 2010-11-08 / 2010-11-09
Schematics 3Schematics / Adobe Acrobat PDF (20 kB) 2010-11-08 /
External PhotosExternal Photos / Adobe Acrobat PDF (104 kB) 2010-11-08 / 2010-11-09
Test Setup PhotosTest Setup Photos / Adobe Acrobat PDF (363 kB) 2010-11-08 / 2010-11-09
Agency LetterCover Letter(s) / Adobe Acrobat PDF (52 kB) 2010-11-08 / 2010-11-09
Agency LetterCover Letter(s) / Adobe Acrobat PDF (52 kB) 2010-11-08 / 2010-11-09
Test ReportTest Report / Adobe Acrobat PDF (988 kB) 2010-11-08 / 2010-11-09
Internal PhotosInternal Photos / Adobe Acrobat PDF (473 kB) 2010-11-08 / 2010-11-09
Users ManualUsers Manual / Adobe Acrobat PDF (1640 kB) 2010-11-08 / 2010-11-09
Confidentiality LetterCover Letter(s) / Adobe Acrobat PDF (76 kB) 2010-11-08 / 2010-11-09
Authorization LetterCover Letter(s) / Adobe Acrobat PDF (168 kB) 2010-11-08 / 2010-11-09
Test Report RevisedTest Report / Adobe Acrobat PDF (835 kB) 2010-11-09 / 2010-11-09
Label and LocationID Label/Location Info / Adobe Acrobat PDF (313 kB) 2010-11-08 / 2010-11-09
Test Report RevisedTest Report / Adobe Acrobat PDF (835 kB) 2010-11-09 / 2010-11-09
Block DiagramBlock Diagram / Adobe Acrobat PDF (20 kB) 2010-11-08 /
External PhotosExternal Photos / Adobe Acrobat PDF (104 kB) 2010-11-08 / 2010-11-09
Test Setup PhotosTest Setup Photos / Adobe Acrobat PDF (363 kB) 2010-11-08 / 2010-11-09

APP # 1 (2010-11-09) Documents

Schematics 1
 2010-11-08 / N/A Schematics / Adobe Acrobat PDF (24 kB)
Confidentiality Letter
 2010-11-08 / 2010-11-09 Cover Letter(s) / Adobe Acrobat PDF (76 kB)
Internal Photos
 2010-11-08 / 2010-11-09 Internal Photos / Adobe Acrobat PDF (473 kB)
Users Manual
 2010-11-08 / 2010-11-09 Users Manual / Adobe Acrobat PDF (1640 kB)
Schematics 2
 2010-11-08 / N/A Schematics / Adobe Acrobat PDF (24 kB)
Description
 2010-11-08 / N/A Operational Description / Adobe Acrobat PDF (20 kB)
Label and Location
 2010-11-08 / 2010-11-09 ID Label/Location Info / Adobe Acrobat PDF (313 kB)
Authorization Letter
 2010-11-08 / 2010-11-09 Cover Letter(s) / Adobe Acrobat PDF (168 kB)
Schematics 3
 2010-11-08 / N/A Schematics / Adobe Acrobat PDF (20 kB)
External Photos
 2010-11-08 / 2010-11-09 External Photos / Adobe Acrobat PDF (104 kB)
Test Setup Photos
 2010-11-08 / 2010-11-09 Test Setup Photos / Adobe Acrobat PDF (363 kB)
Agency Letter
 2010-11-08 / 2010-11-09 Cover Letter(s) / Adobe Acrobat PDF (52 kB)
Agency Letter
 2010-11-08 / 2010-11-09 Cover Letter(s) / Adobe Acrobat PDF (52 kB)
Test Report
 2010-11-08 / 2010-11-09 Test Report / Adobe Acrobat PDF (988 kB)
Internal Photos
 2010-11-08 / 2010-11-09 Internal Photos / Adobe Acrobat PDF (473 kB)
Users Manual
 2010-11-08 / 2010-11-09 Users Manual / Adobe Acrobat PDF (1640 kB)
Confidentiality Letter
 2010-11-08 / 2010-11-09 Cover Letter(s) / Adobe Acrobat PDF (76 kB)
Authorization Letter
 2010-11-08 / 2010-11-09 Cover Letter(s) / Adobe Acrobat PDF (168 kB)
Test Report Revised
 2010-11-09 / 2010-11-09 Test Report / Adobe Acrobat PDF (835 kB)
Label and Location
 2010-11-08 / 2010-11-09 ID Label/Location Info / Adobe Acrobat PDF (313 kB)
Test Report Revised
 2010-11-09 / 2010-11-09 Test Report / Adobe Acrobat PDF (835 kB)
Block Diagram
 2010-11-08 / N/A Block Diagram / Adobe Acrobat PDF (20 kB)
External Photos
 2010-11-08 / 2010-11-09 External Photos / Adobe Acrobat PDF (104 kB)
Test Setup Photos
 2010-11-08 / 2010-11-09 Test Setup Photos / Adobe Acrobat PDF (363 kB)

Grants

TCB Grant from App #1 (2010-11-09)

TCB GRANT OF EQUIPMENT
AUTHORIZATION
TCB
Certification
Issued Under the Authority of the
Federal Communications Commission
By:

  ACB, Inc.
6731 Whittier Avenue Suite C110
McLean, VA 22101
Date of Grant: 11/09/2010

Application Dated: 11/08/2010
Dexcom, Inc.
6340 Sequence Drive
San Diego, CA 92121
 
Attention: Shawn Larvenz , Engineering Director

NOT TRANSFERABLE
EQUIPMENT AUTHORIZATION is hereby issued to the named GRANTEE, and is VALID ONLY for the equipment identified hereon for use under the Commission's Rules and Regulations listed below.
 
FCC IDENTIFIER:  PH29433
Name of Grantee:  Dexcom, Inc.
Equipment Class: Part 15 Low Power Communication Device Transmitter
Notes: Glucose Monitor
Grant Notes  FCC Rule Parts Frequency
Range (MHZ)
Output
Watts
Frequency
Tolerance
Emission
Designator
15C 2425.0  -  2477.0  


EAS Grant from App #1 (2010-11-09)

COPY FEDERAL COMMUNICATIONS
COMMISSION
WASHINGTON, D.C. 20554

GRANT OF EQUIPMENT
AUTHORIZATION
COPY
Certification

Dexcom, Inc.
6340 Sequence Drive
San Diego, CA 92121
United States
  Date of Grant: 11/09/2010

Application Dated: 11/08/2010
 
Attention: Shawn Larvenz , Engineering Director

NOT TRANSFERABLE
EQUIPMENT AUTHORIZATION is hereby issued to the named GRANTEE, and is VALID ONLY for the equipment identified hereon for use under the Commission's Rules and Regulations listed below.
 
FCC IDENTIFIER:  PH29433
Name of Grantee:  Dexcom, Inc.
Equipment Class: Part 15 Low Power Communication Device Transmitter
Notes: Glucose Monitor
Modular Type: Does not apply
Grant Notes  FCC Rule Parts Frequency
Range (MHZ)
Output
Watts
Frequency
Tolerance
Emission
Designator
15C 2425.0  -  2477.0  



Mail To:


EA198809

Applications for this FCC ID

Form App # 1 (2010-11-09)

Application for Equipment Authorization FCC Form 731 TCB Version


Applicant Information
Applicant's complete, legal business name: Dexcom, Inc.
FCC Registration Number (FRN): 0008514325
Alphanumeric FCC ID: PH29433
Unique Application Identifier: qzL7DDdcLkCRsRCVFi4M1w==
Line one: 6340 Sequence Drive
City: San Diego
State: California
Country: United States
Zip Code: 92121

TCB Information
TCB Application Email Address: Hotline@atcb.com
TCB Scope: A2: Low Power Transmitters (except Spread Spectrum) and radar detectors operating above 1 GHz

FCC ID
Grantee Code: PH2
Product Code: 9433

Person at the applicant's address to receive grant or for contact
Name: Shawn Larvenz
Title: Engineering Director
Telephone Number: 858-875-9424 Extension:
Fax Number: 858-200-0202
Email: slarvenz@dexcom.com

Technical Contact
Firm Name: DexCom Inc.
First Name: Shawn
Last Name: Larvenz
Line 1: 6340 Sequence Drive
City: San Diego
State: California
Country:
United States
Zip Code: 92130
Telephone Number:
858 875 9424

Extension:
Fax Number: 858 332 0200
E-Mail:

Long-Term Confidentiality
Does this application include a request for confidentiality for any portion(s) of the data contained in this application pursuant to 47 CFR § 0.459 of the Commission Rules?:   Yes

Short-Term Confidentiality
Does short-term confidentiality apply to this application?:   No
If so, specify the short-term confidentiality release date (MM/DD/YYYY format):  
Note: If no date is supplied, the release date will be set to 45 calendar days past the date of grant.

Software Defined/Cognitive Radio
Is this application for software defined/cognitive radio authorization?   No

Equipment Class
Equipment Class:   DXX - Part 15 Low Power Communication Device Transmitter
Description of product as it is marketed: (NOTE: This text will appear below the equipment class on the grant): Glucose Monitor

Related OET KnowledgeDataBase Inquiry
Is there a KDB inquiry associated with this application?  No

Modular Equipment
Modular Type:  Does not apply

Application Purpose
Application is for:   Original Equipment

Composite/Related Equipment
Is the equipment in this application a composite device subject to an additional equipment authorization?   No
Is the equipment in this application part of a system that operates with, or is marketed with, another device that requires an equipment authorization?   No


Test Firm Information
Name of test firm and contact person on file with the FCC:
Firm Name:   LS Research, LLC
First Name:   Ryan
Last Name:   Urness
Telephone Number: 262-375-4400 Extension:
Fax Number:  262 375 4248
E-mail:  rurness@lsr.com

Grant Comments
Set the grant of this application to be deferred to a specified date:
No

Equipment Authorization Waiver
Is there an equipment authorization waiver associated with this application?  No
If there is an equipment authorization waiver associated with this application, has the associated waiver been approved and all information uploaded?:  No

WILLFUL FALSE STATEMENTS MADE ON THIS FORM ARE PUNISHABLE BY FINE AND IMPRISONMENT (U.S. CODE, TITLE 18, SECTION 1001), AND/OR REVOCATION OF ANY STATION LICENSE OR CONSTRUCTION PERMIT (U.S. CODE, TITLE 47, SECTION 312(a)(1)), AND/OR FORFEITURE (U.S. CODE, TITLE 47, SECTION 503).

SECTION 5301 (ANTI-DRUG ABUSE) CERTIFICATION:
The applicant must certify that neither the applicant nor any party to the application is subject to a denial of Federal benefits, that include FCC benefits, pursuant to Section 5301 of the Anti-Drug Abuse Act of 1988, 21 U.S.C. § 862 because of a conviction for possession or distribution of a controlled substance. See 47 CFR 1.2002(b) for the definition of a "party" for these purposes.

Does the applicant or authorized agent so certify?  Yes

Applicant/Agent Certification:

I certify that I am authorized to sign this application. All of the statements herein and the exhibits attached hereto, are true and correct to the best of my knowledge and belief. In accepting a Grant of Equipment Authorization as a result of the representations made in this application, the applicant is responsible for (1) labeling the equipment with the exact FCC ID specified in this application, (2) compliance statement labeling pursuant to the applicable rules, and (3) compliance of the equipment with the applicable technical rules. If the applicant is not the actual manufacturer of the equipment, appropriate arrangements have been made with the manufacturer to ensure that production units of this equipment will continue to comply with the FCC's technical requirements.

Authorizing an agent to sign this application, is done solely at the applicant's discretion; however, the applicant remains responsible for all statements in this application.

If an agent has signed this application on behalf of the applicant, a written letter of authorization which includes information to enable the agent to respond to the above section 5301 (Anti-Drug Abuse) Certification statement has been provided by the applicant. It is understood that the letter of authorization must be submitted to the FCC upon request, and that the FCC reserves the right to contact the applicant directly at any time.

Signature of Authorized Person Filing:  Shawn Larvenz
Title of authorized signature: 

Applications are submitted for FCC ID and Grant requests. Click an above application to view details


© FCCID.io 2025